Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. No substantive study details or page functionality are affected.SummaryDifference0.0%

- Check16 days agoChange DetectedListed site updated from University of Florida Health Science Center - Gainesville to UF Health Cancer Institute - Gainesville. Added Informed Consent Form PDFs for Part A (Safety Phase) and Part B (Efficacy Phase) with Revision: v3.3.1, and included a Last Update Posted (Estimated) timestamp.SummaryDifference0.5%

- Check23 days agoChange DetectedRemoved the government funding status notice banner from the page, which previously warned that information may not be up to date due to appropriations and directed users to the opm.gov status page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe two screenshots depict the same study page with minor UI/layout adjustments; core study content such as the title, objectives, eligibility, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange DetectedCore page now includes a government funding/operating-status notice and a new version v3.2.0, replacing the older v3.0.2.SummaryDifference2%

- Check81 days agoChange Detected- Updated version label from v3.0.1 to v3.0.2. - Removed the old revision tag (v3.0.1) and a Back to Top cue. - Overall impact appears to be a branding/version update with minimal to no change in core content or user-facing features.SummaryDifference0.1%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.